Moderna 二价 COVID-19 Vaccine Product Leaflet

This leaflet explains the use, benefits, risks, and side effects of Moderna's bivalent COVID-19 vaccine for ages 6 months and up.


Moderna 二价 COVID-19 Vaccine Product Leaflet - cover page
Brand
Moderna
Document type
Product Leaflet
Language
Chinese
Pages
8
File format
PDF
File size
289 KB
Published
31 October, 2026
Updated
31 October, 2026
MD5 checksum
1B362105A3D96EB2B18831BA732054BB

About this manual

This document provides information about the Moderna bivalent COVID-19 vaccine, including its purpose, administration, age groups, contraindications, side effects, and reporting procedures. It is intended for recipients and caregivers to understand the vaccine’s risks and benefits during the ongoing COVID-19 pandemic. The vaccine is authorized for emergency use (EUA) by the FDA but not approved for general use. It targets both original and Omicron BA.4/BA.5 SARS-CoV-2 spike proteins. This manual is written in Chinese.

What's inside

  • About the Vaccine
  • Who Should Get It
  • How It's Administered
  • Contraindications
  • Side Effects
  • Reporting Side Effects
  • Pregnancy and Breastfeeding
  • Vaccine Interactions
  • Contact Information

Frequently asked questions

Who should not get this vaccine?

Those who had a severe allergic reaction to any component of this or other Moderna COVID-19 vaccines.

What is the Moderna bivalent COVID-19 vaccine used for?

It is used to prevent COVID-19 caused by SARS-CoV-2 virus.

Who is eligible to receive the Moderna bivalent COVID-19 vaccine?

It is for individuals aged 6 months and older.

What is the difference between the Moderna bivalent and monovalent COVID-19 vaccines?

The bivalent vaccine encodes both original SARS-CoV-2 and Omicron BA.4/BA.5 spike proteins, while the monovalent vaccine encodes only the original SARS-CoV-2 spike protein.

Download PDF (289 KB)

More Moderna Manuals


View all Moderna manuals →